5-[[2-[2-(3,4-dihydro-2H-1,4-benzoxazin-7-yl)-5-methylpiperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide

C22H25N5O4 — CID 164751436

IUPAC5-[[2-[2-(3,4-dihydro-2H-1,4-benzoxazin-7-yl)-5-methylpiperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide
SMILESCC1CCC(c2ccc3c(c2)OCCN3)N(C(=O)C(=O)Nc2cncc(C(N)=O)c2)C1
InChIInChI=1S/C22H25N5O4/c1-13-2-5-18(14-3-4-17-19(9-14)31-7-6-25-17)27(12-13)22(30)21(29)26-16-8-15(20(23)28)10-24-11-16/h3-4,8-11,13,18,25H,2,5-7,12H2,1H3,(H2,23,28)(H,26,29)
InChIKeyAUVGWESWNWJKKR-UHFFFAOYSA-N
MW423.47 g/mol
LogP1.92
Rot. Bonds3

About 5-[[2-[2-(3,4-dihydro-2H-1,4-benzoxazin-7-yl)-5-methylpiperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide

5-[[2-[2-(3,4-dihydro-2H-1,4-benzoxazin-7-yl)-5-methylpiperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide (PubChem CID 164751436) has the molecular formula C22H25N5O4 and a molecular weight of 423.47 g/mol. Its IUPAC name is 5-[[2-[2-(3,4-dihydro-2H-1,4-benzoxazin-7-yl)-5-methylpiperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide.

Molecular Properties

Compound Name5-[[2-[2-(3,4-dihydro-2H-1,4-benzoxazin-7-yl)-5-methylpiperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide
PubChem CID164751436
Molecular FormulaC22H25N5O4
Molecular Weight423.47 g/mol
Exact Mass423.19
IUPAC Name5-[[2-[2-(3,4-dihydro-2H-1,4-benzoxazin-7-yl)-5-methylpiperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide
SMILESCC1CCC(c2ccc3c(c2)OCCN3)N(C(=O)C(=O)Nc2cncc(C(N)=O)c2)C1
InChIInChI=1S/C22H25N5O4/c1-13-2-5-18(14-3-4-17-19(9-14)31-7-6-25-17)27(12-13)22(30)21(29)26-16-8-15(20(23)28)10-24-11-16/h3-4,8-11,13,18,25H,2,5-7,12H2,1H3,(H2,23,28)(H,26,29)
InChIKeyAUVGWESWNWJKKR-UHFFFAOYSA-N
XLogP1.92
TPSA126.65 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds3
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500423.47
LogP ≤ 51.92
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'diketo_group', 'substructure': 'N/A'}

Analyze 5-[[2-[2-(3,4-dihydro-2H-1,4-benzoxazin-7-yl)-5-methylpiperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-[[2-[2-(3,4-dihydro-2H-1,4-benzoxazin-7-yl)-5-methylpiperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide?
The IUPAC name of 5-[[2-[2-(3,4-dihydro-2H-1,4-benzoxazin-7-yl)-5-methylpiperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide (CID 164751436) is 5-[[2-[2-(3,4-dihydro-2H-1,4-benzoxazin-7-yl)-5-methylpiperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide.
What is the SMILES notation for 5-[[2-[2-(3,4-dihydro-2H-1,4-benzoxazin-7-yl)-5-methylpiperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide?
The canonical SMILES for 5-[[2-[2-(3,4-dihydro-2H-1,4-benzoxazin-7-yl)-5-methylpiperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide is CC1CCC(c2ccc3c(c2)OCCN3)N(C(=O)C(=O)Nc2cncc(C(N)=O)c2)C1.
What is the InChIKey of 5-[[2-[2-(3,4-dihydro-2H-1,4-benzoxazin-7-yl)-5-methylpiperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide?
The InChIKey is AUVGWESWNWJKKR-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H25N5O4/c1-13-2-5-18(14-3-4-17-19(9-14)31-7-6-25-17)27(12-13)22(30)21(29)26-16-8-15(20(23)28)10-24-11-16/h3-4,8-11,13,18,25H,2,5-7,12H2,1H3,(H2,23,28)(H,26,29).
What are the key properties of 5-[[2-[2-(3,4-dihydro-2H-1,4-benzoxazin-7-yl)-5-methylpiperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide?
5-[[2-[2-(3,4-dihydro-2H-1,4-benzoxazin-7-yl)-5-methylpiperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide has a molecular weight of 423.47 g/mol, XLogP of 1.92, 3 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[[2-[2-(3,4-dihydro-2H-1,4-benzoxazin-7-yl)-5-methylpiperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide is sourced from PubChem (CID 164751436), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).